CD4 Lymphocyte Percentage Predicts Disease Progression in HIV‐Infected Patients Initiating Highly Active Antiretroviral Therapy with CD4 Lymphocyte Counts >350 Lymphocytes/mm3

Abstract

BackgroundThe optimal timing of highly active antiretroviral therapy (HAART) in human immunodeficiency virus (HIV)–infected patients with ⩾200 absolute CD4 lymphocytes/mm³ is unknown. CD4 lymphocyte percentage could add prognostic information